Yesterday, March 2, 2016, 118 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $267.02 to $8,394,878.24.

Highlighted Stocks Traded by Insiders:

Gencor Industries (GENC) - FREE Research Report

Houtkin Sherry, who is 10% Owner at Gencor Industries, sold 20,000 shares at $13.54 on March 2, 2016. Following this transaction, the 10% Owner owned 1.3 million shares meaning that the stake was reduced by 1.54% with the 20,000-share transaction.

The shares most recently traded at $13.38, down $0.16, or 1.2% since the insider transaction. Historical insider transactions for Gencor Industries go as follows:

  • 4-Week # shares sold: 59,140
  • 12-Week # shares sold: 78,184
  • 24-Week # shares sold: 158,184

The average volume for Gencor Industries has been 34,000 shares per day over the past 30 days. Gencor Industries has a market cap of $127.8 million and is part of the industrial goods sector and industrial industry. Shares are up 18.58% year-to-date as of the close of trading on Wednesday.

Gencor Industries, Inc., together with its subsidiaries, designs, manufactures, and sells heavy machinery used in the production of highway construction materials, synthetic fuels, and environmental control equipment. The company has a P/E ratio of 148.9. Currently, there are no analysts who rate Gencor Industries a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GENC - FREE

TheStreet Quant Ratings

rates Gencor Industries as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, increase in net income and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Gencor Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

LPL Financial Holdings (LPLA) - FREE Research Report

Dinh Viet D, who is Director at LPL Financial Holdings, bought 4,844 shares at $20.42 on March 2, 2016. Following this transaction, the Director owned 7,731 shares meaning that the stake was boosted by 167.79% with the 4,844-share transaction.

The shares most recently traded at $21.30, up $0.88, or 4.13% since the insider transaction. Historical insider transactions for LPL Financial Holdings go as follows:

  • 4-Week # shares bought: 21,100
  • 4-Week # shares sold: 10,688
  • 12-Week # shares bought: 21,100
  • 12-Week # shares sold: 10,688
  • 24-Week # shares bought: 21,100
  • 24-Week # shares sold: 10,688

The average volume for LPL Financial Holdings has been 1.4 million shares per day over the past 30 days. LPL Financial Holdings has a market cap of $1.9 billion and is part of the financial sector and financial services industry. Shares are down 52.03% year-to-date as of the close of trading on Wednesday.

LPL Financial Holdings Inc., together with its subsidiaries, provides an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at financial institutions in the United States. The stock currently has a dividend yield of 4.77%. The company has a P/E ratio of 12.1. Currently, there is 1 analyst who rates LPL Financial Holdings a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LPLA - FREE

TheStreet Quant Ratings

rates LPL Financial Holdings as a

hold

. Among the primary strengths of the company is its respectable return on equity which we feel is likely to continue. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and poor profit margins. Get the full

LPL Financial Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ResMed (RMD) - FREE Research Report

Reiser Anne, who is President - ResMed Europe at ResMed, sold 1,946 shares at $57.06 on March 2, 2016. Following this transaction, the President - ResMed Europe owned 76,300 shares meaning that the stake was reduced by 2.49% with the 1,946-share transaction.

The shares most recently traded at $57.27, up $0.21, or 0.37% since the insider transaction. Historical insider transactions for ResMed go as follows:

  • 4-Week # shares sold: 30,000
  • 12-Week # shares sold: 34,500
  • 24-Week # shares sold: 59,942

The average volume for ResMed has been 1.3 million shares per day over the past 30 days. ResMed has a market cap of $8.0 billion and is part of the health care sector and health services industry. Shares are up 6.78% year-to-date as of the close of trading on Wednesday.

ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing (SDB). The stock currently has a dividend yield of 2.09%. The company has a P/E ratio of 23.1. Currently, there are 4 analysts who rate ResMed a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RMD - FREE

TheStreet Quant Ratings

rates ResMed as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

ResMed Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.